Remove Atrial Fibrillation Remove Echocardiogram Remove Preserved Ejection Fraction
article thumbnail

PO-01-069 COMPARISON OF DIASTOLIC DYSFUNCTION PARAMETERS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION ACCORDING TO PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION: INSIGHTS FROM THE TOPCAT TRIAL

HeartRhythm

The data on comparison of parameters of diastolic dysfunction (DD) on transthoracic echocardiogram (TTE) according to the progressive stages of AF in patients with coexisting heart failure with preserved ejection fraction (HFpEF) are limited.

article thumbnail

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial

Journal of the American Heart Association

BackgroundHeart failure with preserved ejection fraction ≥50% is prevalent with few evidence‐based therapies. Of the 100 participants, 16 myPACE and 20 usual care arm had a qualifying set of echocardiograms performed a mean (SD) 3 (2.0) Journal of the American Heart Association, Ahead of Print. years apart.

article thumbnail

Effect of Paced Heart Rate on Quality of Life and Natriuretic Peptides for Stage B or C HFpEF: A Secondary Analysis of the myPACE Trial

European Journal of Heart Failure

Abstract Introduction Emerging evidence suggests a beneficial effect of higher heart rates in some patients with heart failure with preserved ejection fraction (HFpEF). Results This study included 93 patients with pre-trial transthoracic echocardiograms available (usual care n=49; myPACE n=44).

article thumbnail

Efficacy and limitation of nonparoxysmal atrial fibrillation ablation in patients with heart failure with preserved ejection fraction

Journal of Cardiovascular Electrophysiology

Abstract Introduction Catheter ablation for atrial fibrillation (AF) reduces heart failure (HF) hospitalization in patients with HF with preserved ejection fraction (HFpEF). However, the long-term outcomes and subclinical HF after nonparoxysmal AF ablation in HFpEF patients have not been fully evaluated.